Selinexor in Combination With MTX+Ritu to Treat R/R CNSL
Selinexor in Combination With MTX+Ritu to Treat R/R CNSL
Recruiting · NCT05698147 · Registry updated 2025-09-16Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Selinexor in Combination With MTX+Ritu to Treat R/R CNSL | primary central nervous system lymphoma | Recruiting | Phase 1 / Phase 2 | 2025-09-16 | NCT05698147 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Antengene Corporation | 2 |
| Tong Chen, MD | 1 |
5 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Beijing Tiantan Hospital, Capital Medical University | Beijing | China | 9 |
| Department of Hematology, Huashan Hospital, Fudan University | Shanghai | China | 1 |
| Oncology Department of The First Affiliated Hospital of Zhengzhou University | Zhengzhou | China | 1 |
| The First Affiliated Hospital of Anhui Medical University | Hefei | China | 44 |
| The First Affiliated Hospital of Fujian Medical University | Fuzhou | China | 21 |